TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34254214

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Prevailing health education
Number of subjects: 512
Study: 33615528

Group type: EXPERIMENTAL
Intervention: Ultrasound-based radiomic features for tumor stage prediction
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Ultrasound-based radiomic features for pathological grade prediction
Number of subjects: 157
Study: 32812137

Group type: EXPERIMENTAL
Intervention: Nonsterile irrigation
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sterile irrigation
Number of subjects: 118
Study: 33212267

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with low-power laser, 660 nm, 40 mW, 120 J/cm2, 4.8 J, 120 s per point and methylene blue (0.005 %) as photosensitizer
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Topical Acyclovir (AC) 5%
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PDT + AC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 32423618

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Elimination diets
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sensitisation to fruits
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sensitisation to grains
Number of subjects: 80

Group type: COMPARATOR
Intervention: Impaction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dysphagia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Abdominal pain
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic findings - exudates
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic findings - trachealisation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic findings - stenosis
Number of subjects: 80
Study: 33788881

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 32826717

Group type: EXPERIMENTAL
Intervention: Ala-Gln at 12g/day
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ala-Gln at 3g/day
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ala-Gln at 6g/day
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ala-Gln at 3g/day, 6g/day, and 12g/day
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ala-Gln
Number of subjects: 140

Group type: COMPARATOR
Intervention: Gly placebo at 12.5g/day
Number of subjects: 140
Study: 33421649

Group type: EXPERIMENTAL
Intervention: Single dose of HPV vaccine (Cervarix or Gardasil-9)
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Two doses of HPV vaccine (Cervarix or Gardasil-9) given 6 months apart
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Three doses of HPV vaccine (Cervarix or Gardasil-9)
Number of subjects: 930
Study: 32187166

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs), primarily Rivaroxaban and Apixaban
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group not specified (standard treatment with warfarin)
Number of subjects: 52
Study: 36242636

Group type: EXPERIMENTAL
Intervention: 5-ALA (20 mg/kg) administered orally or via a gastric tube prior to surgery
Number of subjects: 14
Study: 34182577

Group type: EXPERIMENTAL
Intervention: Parent-administered oral stimulation (PIOMI)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Professional-administered oral stimulation (PIOMI)
Number of subjects: 39
Study: 33903280

Group type: EXPERIMENTAL
Intervention: High-dose intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low-dose intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both doses
Number of subjects: 28
Study: 32202965

Group type: EXPERIMENTAL
Intervention: Regenerative endodontic procedures (REP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional root canal treatment (ENDO)
Number of subjects: 36
Study: 34229508

Group type: EXPERIMENTAL
Intervention: Discrimination experiences
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control for age, education, race, and intervention condition
Number of subjects: 139
Study: 33288629

Group type: EXPERIMENTAL
Intervention: Fixed-dose darbepoetin (0.45 µg/kg every 4 weeks)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Titration-dose darbepoetin (based on hemoglobin levels)
Number of subjects: 756

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 756
Study: 32571338

Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs)
Number of subjects: 135
Study: 34861589

Group type: EXPERIMENTAL
Intervention: Stay Active at Home (SAaH) training program
Number of subjects: 313

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 313
Study: 35175572

Group type: EXPERIMENTAL
Intervention: Cimetidine as adjuvant therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard treatment without cimetidine
Number of subjects: 26
Study: 33138061

Group type: EXPERIMENTAL
Intervention: 30 g/120 kcal whey-protein drink
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 70 g/280 kcal whey-protein drink
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (2 kcal) drink
Number of subjects: 30
Study: 34292492

Group type: EXPERIMENTAL
Intervention: Multidisciplinary care (MDC) program for 12 months
Number of subjects: 50
Study: 33909293

Group type: EXPERIMENTAL
Intervention: Empowerment-psycho-behavioural programme (13 weeks)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Health education programme (control group)
Number of subjects: 250
Study: 37740217

Group type: COMPARATOR
Intervention: Vitamin D supplementation
Number of subjects: 173

Group type: COMPARATOR
Intervention: Maintaining sufficient vitamin D levels
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study: 34697033

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Lifestyle modification
Number of subjects: 3234
Study: 32676977

Group type: COMPARATOR
Intervention: TRV250 (subcutaneous administration)
Number of subjects: 47

Group type: COMPARATOR
Intervention: TRV250 (oral administration)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (oral administration)
Number of subjects: 47
Study: 34467598

Group type: EXPERIMENTAL
Intervention: THC + CBD chemovar (9% THC, 10% CBD)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: CBD-dominant chemovar (1% THC, 23% CBD)
Number of subjects: 159

Group type: COMPARATOR
Intervention: THC-dominant chemovar (24% THC, 1% CBD)
Number of subjects: 159
Study: 32033548

Group type: EXPERIMENTAL
Intervention: Dynamic MRI surgical decision making
Number of subjects: 180

Group type: COMPARATOR
Intervention: Static MRI surgical decision making
Number of subjects: 180
Study: 35472775

Group type: EXPERIMENTAL
Intervention: Serum eye drops (SED)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Plasma rich in growth factors (PRGF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of SED vs. PRGF
Number of subjects: 10
Study: 32971302

Group type: EXPERIMENTAL
Intervention: Manual push technique (MPT)
Number of subjects: 10
Study: 33589450

Group type: EXPERIMENTAL
Intervention: TKI plus local consolidative radiation therapy (LCRT)
Number of subjects: 106

Group type: COMPARATOR
Intervention: TKI alone (standard arm)
Number of subjects: 106
Study: 33228592

Group type: EXPERIMENTAL
Intervention: Glycolysis-related six-gene signature (including GOT1, HSPA5, ANGPTL4, PFKM, IER3, PFKFB4)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Glycolysis-related six-gene signature
Number of subjects: 306
Study: 35072414

Group type: EXPERIMENTAL
Intervention: Outside the room ward rounds
Number of subjects: 891

Group type: COMPARATOR
Intervention: Bedside ward rounds
Number of subjects: 891
Study: 32445004

Group type: EXPERIMENTAL
Intervention: Information‐Motivation‐Behavioral skills (IMB) intervention program based on protection motivation theory
Number of subjects: 117

Group type: COMPARATOR
Intervention: Traditional intervention
Number of subjects: 117
Study: 34991348

Group type: EXPERIMENTAL
Intervention: Response-adaptive randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response-adaptive randomization analysis methods (time-block stratification or re-randomization)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed 1:1 randomization ratio
Number of subjects: 0
Study: 33235123

Group type: EXPERIMENTAL
Intervention: Prewarming group
Number of subjects: 98

Group type: COMPARATOR
Intervention: Warming group
Number of subjects: 98

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 98
Study: 37552354

Group type: EXPERIMENTAL
Intervention: 6-month adjuvant chemotherapy with S-1
Number of subjects: 170

Group type: COMPARATOR
Intervention: 12-month adjuvant chemotherapy with S-1
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 6-month adjuvant chemotherapy with S-1 (in patients who completed the regimen)
Number of subjects: 170

Group type: COMPARATOR
Intervention: 12-month adjuvant chemotherapy with S-1 (in patients who completed the regimen)
Number of subjects: 170
Study: 34339438

Group type: EXPERIMENTAL
Intervention: A‐GPS intervention (quarterly report to clinicians)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Usual care without A‐GPS (control group)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: A‐GPS intervention
Number of subjects: 184
Study: 32799933

Group type: EXPERIMENTAL
Intervention: Dexamethasone plus standard intensive care
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard intensive care alone
Number of subjects: 200
Study: 33994406

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy targeting LDL-C <70 mg/dl
Number of subjects: 5042

Group type: COMPARATOR
Intervention: Standard statin therapy targeting LDL-C 100-120 mg/dl
Number of subjects: 5042
Study: 33068371

Group type: EXPERIMENTAL
Intervention: 3% NaCl nasal irrigation
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl nasal irrigation
Number of subjects: 80
Study: 34891222

Group type: EXPERIMENTAL
Intervention: PPI consultation with people experiencing homelessness aided by Pathway, a UK homeless peer advocacy charity.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Kolb's Experiential Learning Cycle used for team reflection.
Number of subjects: 6
Study: 34256964

Group type: EXPERIMENTAL
Intervention: Pregabalin SR 300 mg once daily for 3 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pregabalin IR 150 mg twice daily for 3 days
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pregabalin SR 300 mg in fed state
Number of subjects: 54
Study: 35182309

Group type: EXPERIMENTAL
Intervention: Adjuvant nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34097646

Group type: EXPERIMENTAL
Intervention: Personalized support at home (monthly home-based visits focusing on nutritional counseling and pregnancy management)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Control group (standard care without personalized support)
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Personalized support at home (more than four home visits)
Number of subjects: 617
Study: 35609265

Group type: EXPERIMENTAL
Intervention: Predictive nomogram incorporating lymphocyte to monocyte ratio (>7.75), neutrophil (>7), AST to ALT ratio (AAR > .86), ALT to lymphocyte ratio index (BLRI > 21.73), alpha‐fetoprotein, and tumor diameter.
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Low probability of VETC group
Number of subjects: 365
Study: 34949626

Group type: EXPERIMENTAL
Intervention: Optimised physiotherapist-led treatment package including advice and education, exercise therapy, and orthotics.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Condition-specific advice, health-promotion advice, exercise types, exercise into 'acceptable' levels of pain, exercise dosage, and type of orthoses.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Electrotherapy, acupuncture, and manual therapy were excluded from the treatment options.
Number of subjects: 15
Study: 35765796

Group type: EXPERIMENTAL
Intervention: Phyto corrective mask (once weekly), phyto corrective gel (twice daily), resveratrol antioxidant serum (at night)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intense pulsed light (IPL) treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both sides treated with sunscreen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Patient satisfaction questionnaire
Number of subjects: 10
Study: 35165099

Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 257

Group type: COMPARATOR
Intervention: Control
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Combination (Lapatinib and Trastuzumab)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Ki67% falls ≥50%
Number of subjects: 257
Study: 34051120

Group type: EXPERIMENTAL
Intervention: Home Biofeedback Therapy (HBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Office Biofeedback Therapy (OBT)
Number of subjects: 30
Study: 32127394

Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab
Number of subjects: 915

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 915
Study: 35311720

Group type: EXPERIMENTAL
Intervention: Bobath therapy with additional specific soft tissue mobilizations
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Bobath intervention
Number of subjects: 40
Study: 33553040

Group type: EXPERIMENTAL
Intervention: 250 g of traditional fermented food (Ash-Kardeh) daily in addition to the usual treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual treatment of diabetic patients
Number of subjects: 44
Study: 32967500

Group type: EXPERIMENTAL
Intervention: ATP group (androl, thalidomide, and PND capsule)
Number of subjects: 82

Group type: COMPARATOR
Intervention: AT group (androl and thalidomide)
Number of subjects: 82
Study: 34139133

Group type: EXPERIMENTAL
Intervention: Music-based interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Person-centered framework for music interventions
Number of subjects: 0
Study: 33866566

Group type: EXPERIMENTAL
Intervention: Iterative Ensemble Smoother (IES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Jacobian approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous increments approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional approach using a full Jacobian matrix
Number of subjects: 0
Study: 35483677

Group type: COMPARATOR
Intervention: Fentanyl 2 μg/kg
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2.5 μg/kg
Number of subjects: 130
Study: 34863115

Group type: EXPERIMENTAL
Intervention: Exercise primed tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise primed sham tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: tDCS alone
Number of subjects: 0
Study: 35438672

Group type: EXPERIMENTAL
Intervention: 30 g potato protein
Number of subjects: 24

Group type: COMPARATOR
Intervention: 30 g milk protein
Number of subjects: 24
Study: 34839483

Group type: EXPERIMENTAL
Intervention: HbA1c at 24 to 28 weeks
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Stable or increasing HbA1c during pregnancy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Decreasing HbA1c during pregnancy
Number of subjects: 125
Study: 32895879

Group type: EXPERIMENTAL
Intervention: Person-centred care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 36240954

Group type: EXPERIMENTAL
Intervention: Repeated low-level red-light (RLRL) therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Single-vision spectacle (SVS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mCT changes at 3 months
Number of subjects: 120
Study: 33653909

Group type: EXPERIMENTAL
Intervention: High-Flow Oxygen Therapy (HFT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy via T-tube
Number of subjects: 22
Study: 35652768

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia with propofol and sevoflurane (PS)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Propofol alone (P)
Number of subjects: 153
Study: 33356982

Group type: EXPERIMENTAL
Intervention: Exercise and isoflavone (Ex+Iso, n = 27 females)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Isoflavone interventions (Iso; n = 16 females)
Number of subjects: 43
Study: 32518063

Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring (FGM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional self-monitoring of blood glucose (SMBG)
Number of subjects: 100
Study: 35818183

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention (nursing support program-based interventions in informational, emotional, and physical dimensions)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Routine ward care (control group)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 74
Study: 34628372

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Epidural Analgesia (PCEA)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Patient-Controlled Intravenous Analgesia (IVPCA)
Number of subjects: 130
Study: 32946257

Group type: EXPERIMENTAL
Intervention: HEAR-aware smartphone app tailored to a person's dynamic stage of readiness and acoustical situations.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HEAR-aware smartphone app
Number of subjects: 0
Study: 34910136

Group type: EXPERIMENTAL
Intervention: Anacetrapib 100 mg daily
Number of subjects: 30449

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 30449
Study: 32504204

Group type: EXPERIMENTAL
Intervention: DynaMesh®-IPOM mesh
Number of subjects: 375

Group type: COMPARATOR
Intervention: Parietex™ Composite mesh
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: DynaMesh®-IPOM mesh with mesh surface area ≤ 300 cm2 and same fixation method (Securestrap™)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Parietex™ Composite mesh with mesh surface area ≤ 300 cm2 and same fixation method (Securestrap™)
Number of subjects: 375
Study: 32823218

Group type: EXPERIMENTAL
Intervention: Single parenteral dose of 300,000 IU of vitamin D
Number of subjects: 46

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 46
Study: 36263570

Group type: EXPERIMENTAL
Intervention: Intermittent aerobic exercise group (IAEG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intermittent aerobic exercise group (IAEG) vs Control group (CG)
Number of subjects: 36
Study: 32962523

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) + Resistance Training (RT) 3x/week
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous High-Intensity Aerobic Exercise (AEX) + RT 3x/week
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both HIIT and AEX
Number of subjects: 26
Study: 32379661

Group type: EXPERIMENTAL
Intervention: Integrative therapy (short-term psychodynamic psychotherapy & cognitive-behavioral therapy)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study: 35354617

Group type: EXPERIMENTAL
Intervention: Standard of care plus immersive virtual reality (VR) experience
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 80
Study: 33795561

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Abrocitinib 30 mg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Abrocitinib 10 mg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 36207050

Group type: EXPERIMENTAL
Intervention: 1.5×10^6 IU of low-dose IL-2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33950931

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 0
Study: 32172199

Group type: EXPERIMENTAL
Intervention: Disease-free survival (DFS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Recurrence-free survival (RFS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Time to recurrence (TTR)
Number of subjects: 24
Study: 34427941

Group type: EXPERIMENTAL
Intervention: 50 mg tapentadol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 10 mg oxycodone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 35713352

Group type: EXPERIMENTAL
Intervention: Dignity therapy (DT) sessions using the Empathic Communication Coding System (ECCS-DT)
Number of subjects: 25
Study: 34231244

Group type: EXPERIMENTAL
Intervention: Peak epileptiform burden
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Age, Acute Physiology and Chronic Health Evaluation II score, seizure on presentation, diagnosis of hypoxic–ischemic encephalopathy
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Model calibration error across 3 strata based on the time interval between last EEG measurement and discharge
Number of subjects: 1967
Study: 33797462

Group type: EXPERIMENTAL
Intervention: Safety Advisor application usage
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Safety Advisor application users
Number of subjects: 181
Study: 34689056

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 33546068

Group type: EXPERIMENTAL
Intervention: Combined general anesthesia and SSPB group (S group)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combined general anesthesia and DSPB group (D group)
Number of subjects: 63

Group type: COMPARATOR
Intervention: General anesthesia group (P group)
Number of subjects: 63
Study: 33130645

Group type: EXPERIMENTAL
Intervention: Proposed treatment protocol including drugs affecting pathogenetic mechanisms of the disease.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Proposed treatment protocol
Number of subjects: 60
Study: 32972467

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral intervention delivered through a smartphone app
Number of subjects: 392

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 392
Study: 33465273

Group type: EXPERIMENTAL
Intervention: VM202
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 32537656

Group type: EXPERIMENTAL
Intervention: Internal health system specialty pharmacy (HSSP)
Number of subjects: 204

Group type: COMPARATOR
Intervention: External specialty pharmacies
Number of subjects: 204